Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: A systematic meta-analysis

Journal of Zhejiang University: Science B

Volumn 15, Issue 10, 2014, Pages 900-906

  Luo, Yue qiu ^a,b,c   Wu, Xiao xing ^a   Ling, Zong xin ^a,c   Cheng, Yi wen ^a,c   Yuan, Li ^a,c   Xiang, Charlie ^a,c  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Fibrosis; Hepatitis C virus; Meta analysis; Vitamin D

Indexed keywords

VITAMIN D; BIOLOGICAL MARKER;

ARTICLE; DISEASE SEVERITY; ETHNICITY; GENOTYPE; HEPATITIS C; HUMAN; LIVER FIBROSIS; META ANALYSIS; VITAMIN BLOOD LEVEL; ADULT; AGED; BLOOD; COMORBIDITY; FEMALE; HEPATITIS C, CHRONIC; INCIDENCE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

HEPATITIS C VIRUS;

ADULT; AGED; BIOLOGICAL MARKERS; COMORBIDITY; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VITAMIN D; YOUNG ADULT;

EID: 84919717713     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1400073     Document Type: Article

References (36)

1. Amanzada, A., Goralczyk, A.D., Moriconi, F., et al., 2013. Vitamin D status and serum ferritin concentration in chronic hepatitis C virus type 1 infection. J. Med. Virol., 85(9):1534–1541. [doi:10.1002/jmv.23632]
2. Arteh, J., Narra, S., Nair, S., 2010. Prevalence of vitamin D deficiency in chronic liver disease. Dig. Dis. Sci., 55(9): 2624–2628. [doi:10.1007/s10620-009-1069-9]
3. Baeke, F., Takiishi, T., Korf, H., et al., 2010. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol., 10(4):482–496. [doi:10.1016/j.coph.2010.04.001]
4. Baur, K., Mertens, J.C., Schmitt, J., et al., 2012. Combined effect of 25-OH vitamin D plasma levels and genetic Vitamin D Receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int., 32(4):635–643. [doi:10.1111/j.1478-3231.2011.02674.x]
5. Cholongitas, E., Theocharidou, E., Goulis, J., et al., 2012. Review article: the extra-skeletal effects of vitamin D in chronic hepatitis C infection. Alimen. Pharmacol. Ther., 35(6):634–646. [doi:10.1111/j.1365-2036.2012.05000.x]
6. Clemens, T.L., Henderson, S.L., Adams, J.S., et al., 1982. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet, 319(8263):74–76. [doi:10.1016/S0140-6736(82)90214-8]
7. Corey, K.E., Zheng, H., Mendez-Navarro, J., et al., 2012. Serum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis. PLoS ONE, 7(2):e27144. [doi:10.1371/journal.pone.0027144]
8. Egger, M., Davey, S.G., Schneider, M., et al., 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ, 315(7109):629–634. [doi:10.1136/bmj.315.7109.629]
9. Geier, A., 2011. Shedding new light on vitamin D and fatty liver disease. J. Hepatol., 55(2):273. [doi:10.1016/j.jhep.2010.12.026]
10. Hennekens, C.H., Demets, D., 2009. The need for large-scale randomized evidence without undue emphasis on small trials, meta-analyses, or subgroup analyses. JAMA, 302(21): 2361–2362. [doi:10.1001/jama.2009.1756]
11. Hewison, M., 2010. Vitamin D and the intracrinology of innate immunity. Mol. Cell. Endocrinol., 321(2):103–111. [doi:10.1016/j.mce.2010.02.013]
12. Hintzpeter, B., Scheidt-Nave, C., Müller, M.J., et al., 2008. Higher prevalence of vitamin D deficiency is associated with immigrant background among children and adolescents in Germany. J. Nutr., 138(8):1482–1490.
13. Holick, M.F., Chen, T.C., 2008. Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr., 87(4):1080S–1086S.
14. Holick, M.F., Chen, T.C., Lu, Z., et al., 2007. Vitamin D and skin physiology: a D-lightful story. J. Bone Miner. Res., 22(Suppl. 2):V28–V33. [doi:10.1359/jbmr.07s211]
15. Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., et al., 2011. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab., 96(7):1911–1930. [doi:10.1210/jc.2011-0385]
16. Hoofnagle, J.H., 2002. Course and outcome of hepatitis C. Hepatology, 36(5 Suppl. 1):S21–S29. [doi:10.1053/jhep.2002.36227]
17. Kitson, M.T., Dore, G.J., George, J., et al., 2013. Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. J. Hepatol., 58(3):467–472. [doi:10.1016/j.jhep.2012.11.017]
18. Ladero, J.M., Torrejón, M.J., Sánchez-Pobre, P., et al., 2013. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C. Ann. Hepatol., 12(2):199–204.
19. Lange, C.M., Bojunga, J., Ramos-Lopez, E., et al., 2011. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J. Hepatol., 54(5):887–893. [doi:10.1016/j.jhep.2010.08.036]
20. Lange, C.M., Miki, D., Ochi, H., et al., 2013. Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development. PLoS ONE, 8(5):e64053. [doi:10.1371/journal.pone.0064053]
21. Micallef, J.M., Kaldor, J.M., Dore, G.J., 2006. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J. Viral Hepat., 13(1):34–41. [doi:10.1111/j.1365-2893.2005.00651.x]
22. Petta, S., Cammà, C., Scazzone, C., et al., 2010. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology, 51(4):1158–1167. [doi:10.1002/hep.23489]
23. Petta, S., Grimaudo, S., Marco, V.D., et al., 2013. Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J. Viral. Hepatitis, 20(7): 486–493. [doi:10.1111/jvh.12072]
24. Poynard, T., Yuen, M.F., Ratzin, V., et al., 2003. Viral hepatitis C. Lancet, 362(9401):2095–2100. [doi:10.1016/S0140-6736(03)15109-4]
25. Romero-Gómez, M., Viloria, M.D.M., Andrade, R.J., et al., 2005. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology, 128(3):636–641. [doi:10.1053/j.gastro.2004.12.049]
26. Shepard, C.W., Finelli, L., Alter, M.J., 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis., 5(9):558–567. [doi:10.1016/S1473-3099(05)70216-4]
27. Stokes, C.S., Volmer, D.A., Grünhage, F., et al., 2013. Vitamin D in chronic liver disease. Liver Int., 33(3): 338–352. [doi:10.1111/liv.12106]
28. Terrier, B., Jehan, F., Munteanu, M., et al., 2012. Low 25-hydroxyvitamin D serum levels correlate with the presence of extra-hepatic manifestations in chronic hepatitis C virus infection. Rheumatology, 51(11):2083–2090. [doi:10.1093/rheumatology/kes209]
29. Thomas, D.L., Seeff, L.B., 2005. Natural history of hepatitis C. Clin. Liver Dis., 9(3):383–398. [doi:10.1016/j.cld.2005.05.003]
30. Tong, J., Wang, Y.W., Lu, Y.A., 2012. New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 13(1):56–82. [doi:10.1631/jzus.B1100120]
31. Villar, L.M., Del Campo, J.A., Ranchal, I., et al., 2013. Association between vitamin D and hepatitis C virus infection: a meta-analysis. World J. Gastroenterol., 19(35):5917. [doi:10.3748/wjg.v19.i35.5917]
32. von Essen, M.R., Kongsbak, M., Schjerling, P., et al., 2010. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat. Immunol., 11(4): 344–349. [doi:10.1038/ni.1851]
33. Wang, T.T., Nestel, F.P., Bourdeau, V., et al., 2004. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol., 173(5):2909–2912. [doi:10.4049/jimmunol.173.5.2909]
34. Weintraub, S.J., Fleckenstein, J.F., Marion, T.N., et al., 2012. Vitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment response. Am. J. Clin. Nutr., 96(5):1025–1031. [doi:10.3945/ajcn.112.039974]
35. White, D.L., Tavakoli-Tabasi, S., Kanwal, F., et al., 2013. The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males. Aliment. Pharmacol. Ther., 38(1):28–37. [doi:10.1111/apt.12341]
36. Zhu, Y., Zheng, Y., Shen, Y.Y., et al., 2014. Analyzing and modeling rheological behavior of liver fibrosis in rats using shear viscoelastic moduli. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 15(4):375–381. [doi:10.1631/jzus.B1300121]